Pharmacogenetics 

GENETIC TESTING IN BOSTON, MASSACHUSETTS

Psychotropic medications can have variable results among individuals depending on their genetic make-up. Cytochrome P450 enzymes are responsible for 70% of medication and chemical metabolism in our body. Gene variation of these enzymes can result in the different metabolism rates of medications and drug-drug interactions.

Genetic testing evaluates a patient’s genetic markers to determine which psychotropic medications are least likely to have side effects and better treatment outcomes. This information can take the guesswork out of psychotropic medication treatment and help physicians provide personalized medicine.

MMC partners with Genelex/Invitae and GeneSight to provide psychotropic medication genetic testing for their patients.